Physician profile
David R Jones
NPI 1538238142
$42,499.48
in general payments reported to CMS, 2019-2025
13 companies · $8,013 in 2025
The $8,013 reported for 2025 was more than what 88% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $4,130 · 2021: $11K · 2022: $2,019 · 2023: $4,149 · 2024: $1,291 · 2025: $8,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,833 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,480 · Travel and Lodging: $1,803 · Grant: $1,495 · Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,833.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,480.00 |
| Travel and Lodging | $1,802.99 |
| Grant | $1,494.51 |
| Food and Beverage | $842.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $12,996.99 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $12,560.91 | 2019-2025 | Tagrisso, Imfinzi |
| Covidien LP | $6,013.01 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $5,380.00 | 2019-2025 | |
| Medtronic, INC. | $3,554.43 | 2022-2023 | Signia |
| Genentech USA, INC. | $1,362.50 | 2021 | |
| Intuitive Surgical, INC. | $296.27 | 2021-2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $97.64 | 2020 | |
| Novocure INC. | $96.42 | 2022 | |
| Organox LTD | $77.89 | 2023 | Metra |
| Biotronik INC. | $24.93 | 2021 | |
| Ethicon INC. | $19.89 | 2019 | |
| Abbott Laboratories | $18.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.